{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T18:05:16Z","timestamp":1782410716004,"version":"3.54.5"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["FSEG-2023-0014"],"award-info":[{"award-number":["FSEG-2023-0014"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jim.2025.113811","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T19:42:46Z","timestamp":1737229366000},"page":"113811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Peptide fibrils as a vaccine: Proof of concept"],"prefix":"10.1016","volume":"538","author":[{"given":"Yana","family":"Zabrodskaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Sivak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sergeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Aleksandrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Kalinina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandr","family":"Taraskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Eropkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Eropkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Egorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2025.113811_bb0005","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1186\/s12864-016-3060-0","article-title":"In vivo Ebola virus infection leads to a strong innate response in circulating immune cells","volume":"17","author":"Caballero","year":"2016","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jim.2025.113811_bb0010","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/21645515.2016.1238535","article-title":"Safety and Immunogenicity of GamEvac-Combi, a Heterologous VSV- and Ad5-Vectored Ebola Vaccine: An Open Phase I\/II Trial in Healthy Adults in Russia","volume":"13","author":"Dolzhikova","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jim.2025.113811_bb0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1134\/S1063774516010065","article-title":"Characterization of oligomerization of a peptide from the Ebola virus glycoprotein by small-angle neutron scattering","volume":"61","author":"Egorov","year":"2016","journal-title":"Crystallogr. Rep."},{"key":"10.1016\/j.jim.2025.113811_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2022.106943","article-title":"Inside and outside of virus-like particles HBc and HBc\/4M2e: a comprehensive study of the structure","volume":"293","author":"Egorov","year":"2023","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.jim.2025.113811_bb0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cvsm.2017.10.002","article-title":"Recent advances in vaccine technologies","volume":"48","author":"Francis","year":"2018","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"10.1016\/j.jim.2025.113811_bb0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/19336896.2023.2194212","article-title":"Viruses and amyloids - a vicious liaison","volume":"17","author":"Hammarstr\u00f6m","year":"2023","journal-title":"Prion"},{"key":"10.1016\/j.jim.2025.113811_bb0035","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1016\/j.vaccine.2020.04.034","article-title":"An effective CTL peptide vaccine for Ebola Zaire based on Survivors\u2019 CD8+ targeting of a particular Nucleocapsid protein epitope with potential implications for COVID-19 vaccine design","volume":"38","author":"Herst","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2025.113811_bb0040","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41580-018-0060-8","article-title":"A new era for understanding amyloid structures and disease","volume":"19","author":"Iadanza","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jim.2025.113811_bb0050","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1016\/j.vaccine.2008.03.078","article-title":"Adjuvant potential of aggregate-forming Polyglutamine domains","volume":"26","author":"Ilyinskii","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2025.113811_bb0055","first-page":"245","article-title":"Describing the Hexapeptide identity platform between the influenza a H5N1 and homo sapiens proteomes","volume":"4","author":"Kanduc","year":"2010","journal-title":"Biologics"},{"key":"10.1016\/j.jim.2025.113811_bb0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/1570163813666160902131603","article-title":"Peptides for Anti-Ebolavirus Vaccines","volume":"13","author":"Kanduc","year":"2016","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.jim.2025.113811_bb0065","first-page":"1933","volume":"13","author":"Krebs","year":"2004","journal-title":"No Title."},{"key":"10.1016\/j.jim.2025.113811_bb0070","first-page":"11","article-title":"Ebola virus disease vaccines: development, current perspectives & challenges","author":"Malik","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jim.2025.113811_bb0075","author":"Saphire"},{"key":"10.1016\/j.jim.2025.113811_bb0080","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-Based Synthetic Vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jim.2025.113811_bb0085","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1080\/22221751.2022.2119169","article-title":"Immunogenicity and Protectivity of Intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine sputnik V in mice and non-human Primates","volume":"11","author":"Tukhvatulin","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jim.2025.113811_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2024.107176","article-title":"How the immune mousetrap works: structural evidence for the immunomodulatory action of a peptide from influenza NS1 protein","volume":"307","author":"Zabrodskaya","year":"2024","journal-title":"Biophys. Chem."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175925000110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175925000110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T06:47:09Z","timestamp":1740725229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175925000110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":17,"alternative-id":["S0022175925000110"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2025.113811","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.12.30.573725","asserted-by":"object"}]},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptide fibrils as a vaccine: Proof of concept","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2025.113811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113811"}}